Wave Life Sciences and Deep Genomics have collaborated to identify new therapies for genetic neuromuscular disorders using Deep Genomics’ machine learning-driven biomedical platform.
Peter P Gariaev’s groundbreaking research in this field has demonstrated that genetic traits can be activated and deactivated through resonant waves directed at their DNA, opening the door for revolutionary technology that could make today’s antiquated recombinant genetic engineering seem as obsolete as Wright Brothers first flight.
What is Wave Genetics?
This press release includes forward-looking statements regarding Deep Genomics’ and Wave’s expectations regarding their respective machine learning platforms and proprietary chemistry platforms for unlocking antisense oligonucleotide therapies for genetic neuromuscular disorders. These statements reflect current beliefs and expectations as well as risks and uncertainties discussed in their most recent annual or quarterly reports filed with the Securities and Exchange Commission.
Wave Genetics scientists are developing ways for us to communicate with our DNA on a conscious level. They have discovered that our genes respond to our thoughts, words, and intentions just like esoteric and spiritual teachers have long noted; this phenomenon has now been scientifically demonstrated that frequencies can reprogram our bodies – yet it takes patience, persistence, and commitment to create healthy quantum communication with DNA.
What is Wave Genetics Technology?
Oligonucleotide therapies developed by this company are designed to target the cause of serious genetic diseases. Delivered directly into cells using an RNA-based delivery system, these therapeutic solutions correct mutations and restore normal functioning for individual cells – this approach addresses genes involved with nervous system function, muscular system functioning and metabolic conditions as well as others.
Wave’s headquarters can be found within Toronto’s MaRS Discovery District, home to four research hospitals, three medical institutes, as well as AI research labs of Google, Uber and Vector Institute for Artificial Intelligence. Wave is supported by leading investors like Capricorn Investments and Fidelity Biomedical Partners.
Researching Lingvistiko-Wave Genetics by Peter P. Garyaev of MOSCOW STATE UNIVERSITY. His theory serves as a fundamental correction of current discrete particle ideas of genetic code.
Why is Wave Genetics being ignored?
Truth be told, GMO research is being avoided because it threatens a massive GMO product business that brings billionaires massive profits while simultaneously contributing to humanity’s slow degeneration. History shows us that most significant discoveries were initially disregarded before being challenged by skeptical thinkers until eventually becoming self-evident.
This press release contains forward-looking statements. These statements relate to future events or results of operations, including expectations regarding deepening understanding of splicing biology, expanding druggable targets and expanding patient populations. Such forward-looking statements are based on current beliefs and expectations but involve risks that may cause actual results to differ materially, including factors like drug development, regulatory approval processes and commercialization; see Wave’s most recent annual or quarterly reports filed with U.S. Securities and Exchange Commission for more details.
